Key Points Johnson & Johnson has a deep and diversified pharmaceutical portfolio. The company's robotic surgical system, Ottava, could become a meaningful growth driver. Johnson & Johnson has a fantastic dividend track record. 10 stocks we like better than Johnson & Johnson › Johnson & Johnson (NYSE: JNJ) seems to be firing on all cylinders. The company's financial results have been strong this year, leading to a solid stock market performance. Johnson & Johnson's shares aren't too far from their all-time highs right now. However, even at current levels, it's worth investing in the company, at least for investors focused on the long game. Let's consider three reasons why. Image source: The Motley Fool. Missed AI’s "Act 1"? Act 2 Could Be 15x Bigger.
Chung toi hien cong khai y chinh. Tao tai khoan mien phi de doc toan bo bai viet, luu, thao luan va ket noi voi boi canh thi truong va OSINT.